Shares of GeneNews Ltd. (OTCMKTS GNWSF) opened at $0.11 on Tuesday. The company has a current ratio of 0.08, a quick ratio of 0.05 and a debt-to-equity ratio of -0.59. GeneNews Ltd. has a 1-year low of $0.06 and a 1-year high of $0.39.
ILLEGAL ACTIVITY WARNING: This piece was originally posted by Stock Observer and is the sole property of of Stock Observer. If you are reading this piece on another site, it was stolen and republished in violation of international trademark and copyright law. The original version of this piece can be viewed at https://www.thestockobserver.com/2017/11/14/genenews-ltd-gnwsf-scheduled-to-post-earnings-on-wednesday.html.
GeneNews Company Profile
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Receive News & Ratings for GeneNews Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.